Open access
Oct 2026
EFFECTIVENESS OF EMPAGLIFLOZIN AND LINAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES: PHYSICIAN INSIGHTS FROM SOUTHERN INDIA
Background: Type 2 diabetes mellitus (T2DM) is a chronic global health burden associated with cardiovascular (CV) and renal complications. This study aimed to evaluate real-world efficacy, cardiometabolic outcomes, and long-term outcomes of the empagliflozin + linagliptin add-on therapy to metformin in T2DM patients. M...
Nandkishor Shingne, Vrunda Patel, Swati Tiwari et al.
· World Journal of Advanced Re... · 0 citations